Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


07.01.2019

1 Acta Neuropathol
1 Am J Alzheimers Dis Other Demen
1 Ann Neurol
1 Brain
2 Curr Alzheimer Res
2 J Alzheimers Dis
1 Neurobiol Aging
1 Neurobiol Dis
1 Neurosci Lett
1 Neuroscience
1 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. VERGARA C, Houben S, Suain V, Yilmaz Z, et al
    Amyloid-beta pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo.
    Acta Neuropathol. 2019 Jan 1. pii: 10.1007/s00401-018-1953.
    PubMed     Text format     Abstract available


    Am J Alzheimers Dis Other Demen

  2. ASADOLLAHI M, Atazadeh M, Noroozian M
    Seizure in Alzheimer's Disease: An Underestimated Phenomenon.
    Am J Alzheimers Dis Other Demen. 2018 Dec 30:1533317518813551.
    PubMed     Text format     Abstract available


    Ann Neurol

  3. HARRISON TM, La Joie R, Maass A, Baker SL, et al
    Longitudinal tau accumulation and atrophy in aging and Alzheimer's disease.
    Ann Neurol. 2018 Dec 31. doi: 10.1002/ana.25406.
    PubMed     Text format     Abstract available


    Brain

  4. ZHU BL, Long Y, Luo W, Yan Z, et al
    MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation.
    Brain. 2019;142:176-192.
    PubMed     Text format     Abstract available


    Curr Alzheimer Res

  5. HU Y, Zhou G, Zhang C, Zhang M, et al
    Identify compounds's target against Alzheimer's disease based on silico approach.
    Curr Alzheimer Res. 2019 Jan 3. pii: CAR-EPUB-95587.
    PubMed     Text format     Abstract available

  6. KOO HKYG, Schweizer TA, Fischer CE, Munoz DG, et al
    Abnormal Sleep Behaviours Across the Spectrum of Alzheimer's Disease Severity: Influence of APOE Genotypes and Lewy Bodies.
    Curr Alzheimer Res. 2019 Jan 3. pii: CAR-EPUB-95588.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  7. OECKL P, Halbgebauer S, Anderl Straub S, Steinacker P, et al
    Glial Fibrillary Acidic Protein in Serum Is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment.
    J Alzheimers Dis. 2018 Dec 24. pii: JAD180325. doi: 10.3233/JAD-180325.
    PubMed     Text format     Abstract available

  8. TURCHETTA CS, Perri R, Fadda L, Caruso G, et al
    Forgetting Rate on the Recency Portion of a Word List Differentiates Mild to Moderate Alzheimer's Disease from Other Forms of Dementi.
    J Alzheimers Dis. 2018 Dec 28. pii: JAD189013. doi: 10.3233/JAD-189013.
    PubMed     Text format    


    Neurobiol Aging

  9. JIANG B, Zhou J, Li HL, Chen YG, et al
    Mutation screening in Chinese patients with familial Alzheimer's disease by whole-exome sequencing.
    Neurobiol Aging. 2018 Dec 6. pii: S0197-4580(18)30433.
    PubMed     Text format     Abstract available


    Neurobiol Dis

  10. RYSKAMP D, Wu L, Wu J, Kim D, et al
    Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor.
    Neurobiol Dis. 2018 Dec 27. pii: S0969-9961(18)30595.
    PubMed     Text format     Abstract available


    Neurosci Lett

  11. DONG Q, Teng SW, Wang Y, Qin F, et al
    Sitagliptin protects the cognition function of the Alzheimer's disease mice through activating glucagon-like peptide-1 and BDNF-TrkB signalings.
    Neurosci Lett. 2018 Dec 28. pii: S0304-3940(18)30898.
    PubMed     Text format     Abstract available


    Neuroscience

  12. MONDRAGON-RODRIGUEZ S, Gu N, Fasano C, Pena-Ortega F, et al
    dFunctional connectivity between Hippocampus and Lateral septum is affected in very young Alzheimer's transgenic mouse model.
    Neuroscience. 2018 Dec 29. pii: S0306-4522(18)30868.
    PubMed     Text format     Abstract available


    Rev Neurol

  13. GARCIA-PENAS JJ
    [Epilepsy, cognition and ketogenic diet].
    Rev Neurol. 2018;66.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: